期刊文献+

氨基末端脑钠肽对老年血液透析合并充血性心力衰竭的心功能诊断分级的判断价值 被引量:7

Self-control study of changes in serum NT-proBNP on elderly hemodialysis and non-dialysis patients with heart failure
下载PDF
导出
摘要 目的探讨氨基末端脑钠肽(N terminal-pro brain nalriuretic peptide,NT-proBNP)水平变化对老年血液透析合并充血性心力衰竭诊断和心功能分级的判断价值。方法选择尿毒症维持性血液透析(maintenance hemodialysis,MHD)合并心力衰竭患者36例作为血透心衰组,选择非血液透析、CKD3期以上[eGFR>60 ml/(min·1.73m2)]的心力衰竭患者38例作为对照组,测定两组心力衰竭及治疗好转后心功能不同等级时的NT-proBNP,采用受试者工作特征(receive operating characteristic,ROC)曲线评价NT-proBNP的诊断效能。结果血透心衰组和对照组治疗后随心功能好转,血清NT-proBNP水平下降,不同心功能分级间NT-proBNP水平有统计学差异(P<0.05或P<0.01)。血透心衰组各心功能分级NT-proBNP水平明显高于对照组,差异有统计学意义(P<0.05)。血透心衰组心功能Ⅳ级AUC值为0.847,NT-proBNP>11 100 ng/L作为界值(cutoff值)的敏感度为83%,特异度为79%;心功能Ⅲ级AUC值为0.794,NT-proBNP>6465 ng/L作为界值的敏感度为100%,特异度为56.4%,心功能Ⅰ级和Ⅱ级时无统计学差异。结论老年MHD合并心力衰竭时NT-proBNP可作为判断心力衰竭及心功能Ⅲ级、Ⅳ级的分级指标。 Objective To evaluate the changes level of amino terminal brain natriuretic peptide (NT-proBNP) as well as its relationship between the changes and cardiac function classification in elderly maintenance hemodialysis patients with congestive heart failure. Methods Self-reflection methods was used to analyze clinical data in 36 maintenance hemodialysis patients with congestive heart failure (hemodialysis heart failure group)aged≥60 years and compared with 38 non-maintenance hemodialysis patients with congestive heart failure (control group ) aged ≥ 60 years whose estimated glomerular filtration rate (eGFR) 〉60 ml/(min · 1.73 m2) more than 60 years old among the same period in this hospital. The NT-proBNP level of different grades classified by NYHA ( New York Heart Association) in the two group' s patients was measured after the treatment to improve cardiac function. ROC curve was used to evaluate diagnosis efficiency of NT - proBNP in different cardiac function classification of hemodialysis heart failure group. Results In hemodialysis heart failure group, compared with control group, NT-proBNP level of various cardiac function classification, median NT-proBNP values of Ⅰ , Ⅱ, Ⅲ, Ⅳ cardiac function classification respectively were significantly higher (P 〈0.05 or P 〈 0.01 ). Comparing NT-proBNP level between different heart function classification in hemodialysis heart failure group, adjacent grading levels Ⅱ-Ⅳ also had significant difference (P 〈 0.05 or P 〈 0.01 ), and levels Ⅰ -Ⅱ have no significant difference (P 〉 0.05 ). The same comparison in control group, adjacent grading levels Ⅰ -Ⅳ all have significant differences (P 〈 0.05 or P 〈0.01 ). AUC value results in hemodialysis heart failure group: AUC value in grade IV was 0. 847, NT-proBNP 〉 11 100 ng/L as boundary values, sensitivity was 83%, specificity was 79% ; AUC value in grade m was o. 794, NT-proBNP 〉 6465 ng/L as boundary values, sensitivity was 100%, specificity was 56.4% ; cardiac function classification Ⅰ , Ⅱ were meaningless. Conclusions NT- proBNP can be regarded as diagnostic index and grading index of Ⅲ Ⅳ in elderly hemodialysis patients with congestive heart failure.
出处 《武警医学》 CAS 2014年第6期566-569,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 维持性血液透析 氨基末端脑钠肽 纽约心脏病协会 受试者操作特征曲线下面积 maintenance hemodialysis N terminal-pro brain nalriuretic peptide New York Heart Association under receiv- er-operator characteristic curve
  • 相关文献

参考文献15

  • 1Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain [ J]. Nature, 1988,332 (159) :78-81.
  • 2汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 3Maisel A S, Kfishnaswamy P, Nowak R M, et al. Rapid measurement of B-type natriuretic peptide in the emer- gency diagnosis of heart failure[ J]. N Eng J Med,2002, 347 ( 3 ) : 161-167.
  • 4Austin W J, Bhalla V, Hernandez-Arce I, et al. Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease [ J ]. Am J Clin Pathol, 2006,126 (4) : 506-512.
  • 5Van Kimmenade R R, Januzzi J L, Baggish A L, et al. A- mino-terminal probrain natriuretic peptide, renal func- tion, and outcomes in acute heart failure:redefining the cardiorenal interaction [ J ]. J Am Coll Cardiol, 2006,48 ( 8 ) : 1621-1627.
  • 6Tagore R, Ling L H iYang H, et al. Natriuretic peptides in chronic kidney disease [ J ]. Clin J Am Soc Nephrol,2008,3(6) :1644-1651.
  • 7Van Kimmenade R R, Januzzi J L, Bakker J A, et al. Re- nal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanistic study in hypertensive subjects [ J ]. J Am Coll Cardiol, 2009,53 (10) : 884-890.
  • 8Reichek N, Devereux R B. Left ventrictllar hypertrophy: Relationship of anatomic, echocardiographic and elecch- ocardiographic findings [ J ]. Circulation, 1981,63 ( 6 ) : 1391-1398.
  • 9Zhu Y, Zhang F,Zhang F C, et al. Risk factors elated to left ventricular hypertrophy in elderly hypertension patients [ J ]. J Chin Clin Med, 2006,13 ( 6 ) : 308-313.
  • 10Roberts M A, Hedley A J, Ierino F L. Understanding cardiac biomarkers in end-stage kidney disease: frequently asked questions and the promise of clinical application [ J ]. Nephrology (Carlton) ,2011,16 ( 3 ) : 251-260.

二级参考文献11

  • 1Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department(PRIDE) study. Am J Cardiol.2005 .95 :948-954.
  • 2Pemberton C J, Yandle TG, Radenmker MT, et al. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload. Am J Physiol, 1998, 275:1200-1208.
  • 3Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J, 1990,120:1532-1537.
  • 4Yeo KT, Wu AH, Apple FS, et aL Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338: 107-115.
  • 5Tsutsmoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide levels as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J, 1999, 20:1799-1807.
  • 6Omland T, Aakvaag A, Bonarjee WS,et aL Plasma brain natriuretic peptide as an indicator of left ventricular systolic dysfunction and long-term survival after acute myocardial infarction: comparion with plasma atrial natriuretic peptide and N-terminal proatria natriuretic peptide. Circulation, 1996,93 : 1963-1969.
  • 7Mc Donagh T, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic poptide, and mortality in an urban population. Heart,2001,86:21-26.
  • 8Squire IB, O'Brien RJ, Demme B, et al. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci,2004, 107:309-316.
  • 9Richard MA, Nicholls GM, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin : new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation, 1998, 97 : 1921-1929.
  • 10Bazzino O, Fuselli JJ, Botto F, et al. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J, 2004, 25:859-866.

共引文献82

同被引文献63

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部